KALA BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.512 USD | +0.18% |
|
-0.59% | -6.98% |
| 05-17 | HC Wainwright Adjusts Kala Pharmaceuticals Price Target to $18 From $21, Maintains Buy Rating | MT |
| 04-02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 18.34M | - | - | - | - | - | |
| 727B | ||||||
| 599B | ||||||
| 354B | ||||||
| 328B | ||||||
| 277B |
- Stock Market
- Equities
- KALA Stock
- Charts KALA BIO, Inc.
- Sector Chart
